Lab-on-a-chip (LOC) biological assays have the potential to fundamentally reform healthcare. The move away from centralized facilities to Point-of-Care (POC) testing of biological assays would improve the speed and accuracy of these, thereby improving patient care. Before LOC can be realized, a number of challenges must be addressed: the need for expert users must be abstracted away; the manufacturing cost of $5 per test threshold must be met; and the supporting infrastructure must be integrated down to an easily portable size. These challenges can be addressed with the deposition of microfluidics on CMOS chips. By designing application specific integrated circuits (ASICs) much of the automation and the supporting infrastructure needed to run these assays can be integrated into the chip. Additionally, CMOS fabrication is some of the most optimized manufacturing in industry today. My parents, thank you for providing me with food and shelter while in Alberta and never ending support while I was in Ontario. Keesa, my lovely fiance, without you I never would have gotten this far; probably not even close. Evelyn, your kitchen table debates over genetics and technology pushed me to discover new knowledge; endless appreciation.To my colleges at the U of A: